Retrophin Inc (NASDAQ:RTRX)

27.60
Delayed Data
As of Jun 21
 -0.40 / -1.43%
Today’s Change
18.70
Today|||52-Week Range
29.78
+30.99%
Year-to-Date
No recent news for Retrophin Inc.

Today’s Trading

Previous close28.00
Today’s open28.11
Day’s range27.39 - 28.11
Volume187,582
Average volume (3 months)346,282
Market cap$1.1B
Data as of 4:00pm ET, 06/21/2018

Growth & Valuation

Earnings growth (last year)-19.38%
Earnings growth (this year)-215.38%
Earnings growth (next 5 years)+137.00%
Revenue growth (last year)+15.98%
P/E ratioNM
Price/Sales5.27
Price/Book3.59

Competitors

 Today’s
change
Today’s
% change
FPRXFive Prime Therapeut...-0.55-3.11%
EDITEditas Medicine Inc-1.23-3.00%
EPZMEpizyme Inc-0.90-5.66%
----
Data as of 4:00pm ET, 06/21/2018

Financials

Next reporting dateAugust 8, 2018
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$154.9M
Annual profit (last year)-$59.7M
Net profit margin-38.55%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stephen J. Aselage
Chief Operating Officer
Neil F. McFarlane
Corporate headquarters
San Diego, California

Forecasts